JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$4.76B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.21B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$3.81B |
| 4 |
Apple
AAPL
|
+$3.39B |
| 5 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$3.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.48B |
| 2 |
S&P Global
SPGI
|
+$2.45B |
| 3 |
Coca-Cola
KO
|
+$1.73B |
| 4 |
Adobe
ADBE
|
+$1.59B |
| 5 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$1.3B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.97% |
| 2 | Technology | 21.69% |
| 3 | Healthcare | 9.58% |
| 4 | Consumer Discretionary | 9.07% |
| 5 | Financials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
6451
Xos
XOS
$47.1M
| $563 | ﹤0.01% |
55
+53
| +2,650% | +$497 |
2022 Q2
7 quarters
|
|
6452
Direxion Daily Gold Miners Index Bear 2X ETF
DUST
$106M
| $560 | ﹤0.01% |
+1
| New | +$1.2K |
2024 Q1
0 quarters
|
|
6453
AdvisorShares Dorsey Wright ADR ETF
AADR
$37.7M
| $554 | ﹤0.01% |
8
| – | – |
2022 Q4
5 quarters
|
|
|
SCTL
6454
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $542 | ﹤0.01% |
+502
| New | +$323 |
2024 Q1
0 quarters
|
|
|
CNF
6455
CNFinance Holdings
CNF
$33.7M
| $538 | ﹤0.01% |
+26
| New | +$569 |
2023 Q2
3 quarters
|
|
|
ADVM
6456
DELISTED
Adverum Biotechnologies
ADVM
| $537 | ﹤0.01% |
38
-3
| -7% | -$46 |
2014 Q3
38 quarters
|
|
6457
Immunic
IMUX
$109M
| $537 | ﹤0.01% |
41
| – | – |
2020 Q2
15 quarters
|
|
|
TUP
6458
DELISTED
Tupperware Brands Corporation
TUP
| $535 | ﹤0.01% |
399
-3,938
| -91% | -$6.28K |
2013 Q2
43 quarters
|
|
6459
Inseego
INSG
$79.7M
| $532 | ﹤0.01% |
190
| – | – |
2016 Q4
29 quarters
|
|
6460
ProShares VIX Short-Term Futures ETF
VIXY
$216M
| $531 | ﹤0.01% |
10
+2
| +25% | +$114 |
2023 Q4
1 quarter
|
|
6461
Global X Guru Index ETF
GURU
$60.4M
| $522 | ﹤0.01% |
12
| – | – |
2022 Q4
5 quarters
|
|
|
YARW
6462
Yarrow Bioscience
YARW
$169M
| $520 | ﹤0.01% |
3
| – | – |
2022 Q3
6 quarters
|
|
|
HART
6463
DELISTED
IQ Healthy Hearts ETF
HART
| $512 | ﹤0.01% |
17
| – | – |
2022 Q4
5 quarters
|
|
6464
Xtrackers Municipal Infrastructure Revenue Bond Active ETF
RVNU
$130M
| $511 | ﹤0.01% |
19
-2,318
| -99% | -$59.4K |
2023 Q3
2 quarters
|
|
6465
ProShares UltraShort Real Estate
SRS
$17.6M
| $510 | ﹤0.01% |
9
| – | – |
2023 Q2
3 quarters
|
|
6466
Neurogene
NGNE
$523M
| $509 | ﹤0.01% |
10
| – | – |
2020 Q1
16 quarters
|
|
|
FSFG
6467
DELISTED
First Savings Financial Group
FSFG
| $503 | ﹤0.01% |
30
| – | – |
2021 Q4
9 quarters
|
|
|
BKYI
6468
BIO-key International
BKYI
$2.8M
| $501 | ﹤0.01% |
+24
| New | +$485 |
2024 Q1
0 quarters
|
|
6469
Quince Therapeutics
QNCX
$29.3M
| $497 | ﹤0.01% |
2
| – | – |
2019 Q2
19 quarters
|
|
6470
CEL-SCI Corp
CVM
$42.9M
| $495 | ﹤0.01% |
9
| – | – |
2019 Q2
19 quarters
|
|
|
JFU
6471
9F Inc
JFU
$32.3M
| $489 | ﹤0.01% |
139
-128
| -48% | -$390 |
2020 Q2
15 quarters
|
|
6472
Nephros
NEPH
$38.9M
| $484 | ﹤0.01% |
221
+211
| +2,110% | +$669 |
2023 Q3
2 quarters
|
|
6473
ProMIS Neurosciences
PMN
$83.1M
| $484 | ﹤0.01% |
10
-6
| -38% | -$297 |
2022 Q3
6 quarters
|
|
6474
IZEA Worldwide
IZEA
$44.1M
| $478 | ﹤0.01% |
207
-8
| -4% | -$16 |
2022 Q3
6 quarters
|
|
|
AOD
6475
abrdn Total Dynamic Dividend Fund
AOD
$1.07B
| $473 | ﹤0.01% |
57
-32
| -36% | -$258 |
2022 Q4
5 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2024 Portfolio in Review
As of Q1 2024, JP Morgan Chase held 8,132 positions worth $1.18T, up 14% from $1.04T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
JP Morgan Chase deployed $48.7B of net new capital in Q1 2024, opening 625 new positions and adding to 3,255 existing holdings. Its largest new stake was Flutter Entertainment: 1,314,201 shares worth $260M.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vanguard Total International Bond ETF, an estimated $2.48B trimmed.
- JP Morgan Chase's largest Q1 2024 buy was Flutter Entertainment: 1,314,201 shares worth $260M.
- JP Morgan Chase added most to Vanguard S&P 500 ETF in Q1 2024, an estimated $4.76B increase.
- JP Morgan Chase's biggest Q1 2024 reduction was Vanguard Total International Bond ETF, cutting an estimated $2.48B.
- JP Morgan Chase fully exited BlackRock Flexible Income ETF in Q1 2024, selling an estimated $139M.
- JP Morgan Chase's ten largest holdings make up 21% of its $1.18T portfolio in Q1 2024.
- JP Morgan Chase opened 625 new positions and closed 764 in Q1 2024.
- JP Morgan Chase's portfolio value rose 14% quarter-over-quarter to $1.18T.
Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.